Dendritic cells are functionally defective in multiple myeloma: the role of interleukin-6. - Wikidata - wikimedia - TriplyDB

Dendritic cells are functionally defective in multiple myeloma: the role of interleukin-6.

Dendritic cells are functionally defective in multiple myeloma: the role of interleukin-6.

http://www.wikidata.org/entity/Q51045048

about

Biological activity of lenalidomide and its underlying therapeutic effects in multiple myeloma Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myeloma The use of lentinan for treating gastric cancer The Role of Immunotherapy in Multiple Myeloma Myeloid-derived suppressor cells as therapeutic target in hematological malignancies Development of Novel Immunotherapies for Multiple Myeloma Bovine lactoferrin counteracts Toll-like receptor mediated activation signals in antigen presenting cells Direct association between pharyngeal viral secretion and host cytokine response in severe pandemic influenza Extracellular hepatitis C virus core protein activates STAT3 in human monocytes/macrophages/dendritic cells via an IL-6 autocrine pathway.Functional interaction of plasmacytoid dendritic cells with multiple myeloma cells: a therapeutic target.Either interleukin-12 or interferon-gamma can correct the dendritic cell defect induced by transforming growth factor beta in patients with myeloma.Decreased expression of indoleamine 2,3-dioxygenase 1 in dendritic cells contributes to impaired regulatory T cell development in immune thrombocytopenia.Variation and significance of secretory immunoglobulin A, interleukin 6 and dendritic cells in oral cancer.A novel TLR-9 agonist C792 inhibits plasmacytoid dendritic cell-induced myeloma cell growth and enhance cytotoxicity of bortezomib.Alterations of dendritic cell subsets in the peripheral circulation of patients with cervical carcinoma Bone marrow microenvironment in myelomagenesis: its potential role in early diagnosis.T cells from the tumor microenvironment of patients with progressive myeloma can generate strong, tumor-specific cytolytic responses to autologous, tumor-loaded dendritic cells.Regulation of dendritic cell differentiation and antitumor immune response in cancer by pharmacologic-selective inhibition of the janus-activated kinase 2/signal transducers and activators of transcription 3 pathway The key role of CD40 ligand in overcoming tumor-induced dendritic cell dysfunction.Patient-tailored modulation of the immune system may revolutionize future lung cancer treatment.A population of HLA-DR+ immature cells accumulates in the blood dendritic cell compartment of patients with different types of cancer.HLA-DR+ immature cells exhibit reduced antigen-presenting cell function but respond to CD40 stimulation Exogenous control of the expression of Group I CD1 molecules competent for presentation of microbial nonpeptide antigens to human T lymphocytes Application of the molecular analysis of the T-cell receptor repertoire in the study of immune-mediated hematologic diseases.Dendritic cell-based immunotherapy for the treatment of hematological malignancies.Optimizing DC vaccination by combination with oncolytic adenovirus coexpressing IL-12 and GM-CSF.Against the self: dendritic cells versus cancer.Dendritic cells and malignant plasma cells: an alliance in multiple myeloma tumor progression?Anti-idiotype vaccines.The immune microenvironment of myeloma Dendritic cells and their potential therapeutic role in haematological malignancy.The frequency of T regulatory cells modulates the survival of multiple myeloma patients: detailed characterisation of immune status in multiple myeloma.Optimizing parameters for clinical-scale production of high IL-12 secreting dendritic cells pulsed with oxidized whole tumor cell lysate Therapeutic idiotype vaccines in B lymphoproliferative diseases.Optimizing immunotherapy in multiple myeloma: Restoring the function of patients' monocyte-derived dendritic cells by inhibiting p38 or activating MEK/ERK MAPK and neutralizing interleukin-6 in progenitor cells Immunotherapy using dendritic cells against multiple myeloma: how to improve?Cellular immunotherapy using dendritic cells against multiple myeloma Induction of potent NK cell-dependent anti-myeloma cytotoxic T cells in response to combined mapatumumab and bortezomib.Targeted therapy in multiple myeloma.Dendritic cells accumulate in the bone marrow of myeloma patients where they protect tumor plasma cells from CD8+ T-cell killing.

P2860

Q21285161-07285059-E3F8-4542-ACF7-2304F35F6287 Q24605861-1376E677-7E50-4A17-AB8C-A3E02B06163C Q24619416-16DC2995-2AD7-4D71-8209-A19361A2AFDF Q26771144-5EF8BD62-9353-476E-BC6A-C6BB4DEADA26 Q27010234-A1FF1655-B786-4140-A1DB-6D5995267184 Q28066890-A212BBDC-EB7D-4843-99E7-07292D4215E4 Q28742177-86237C1A-3DED-417D-A878-15E0EFDB897E Q30406559-17D155F3-A9F6-434D-828B-DF644DFA6340 Q30427748-983651C3-B6B4-43AC-ADB6-9F820150AC06 Q30490975-4B3F632F-48C0-4A85-B29C-E66E1A22C314 Q33203486-78A184DA-1B93-4B11-8666-C2BFFCA5D7A1 Q33403052-584E9186-A6BC-4C8E-BED1-7FAA099A55FE Q33598073-73CB23F5-D148-496B-9AEB-7762D9F9B84F Q33976734-09AD4992-67B3-4E8D-9FC2-C06B537578CC Q33997905-4E05D63A-4338-4788-8939-7881DEA04F54 Q34155848-F1C4567A-364C-498A-BF57-5612C2C4BE91 Q34191186-D4C8A97F-1C4D-4353-A8A0-42E22F9C0C2E Q34314210-F3F82DBF-6CD2-43E0-A404-242E1405F379 Q34480605-B74B4494-B6E5-44A0-A4A0-122112C737EF Q34502899-D8B66BA4-27E9-411F-8505-6324DBB75417 Q34768502-738D9BF4-AC6B-4711-A84F-5FEDCD4ABE01 Q34768526-29F3FE0E-2A41-494E-8F91-BA83575F4FD0 Q34983782-A68733EC-D2FE-4364-8922-A66276441E9F Q35126995-29EC7C83-D000-4406-88C4-3CAD28879EB8 Q35127001-163A0D43-3794-4585-86C6-4B39D3ABA934 Q35144428-3630C380-81BF-400B-90DD-90B6AAA5F81D Q35219334-D35350A3-FA2A-4AEE-98E8-508C0B928BF0 Q35584599-26530FF5-7AD9-45AF-B8F7-55FBCA081CAA Q35591089-28A482B5-DF5F-452A-BDD0-732A05C9765D Q35603152-87E5D040-DE15-4EC4-A916-43DF0C217EC8 Q35614625-0CD72A15-4C03-4F6F-A788-A22273E720F7 Q35739463-D2DA3A8C-4587-4E4E-B3D3-412DD72182D4 Q35768996-FDE5B8BD-6083-4109-A462-A680D6E31681 Q35790890-4ABE1FAC-DC8F-4F4F-B863-20CE1305332F Q35848756-0F84821D-7AF1-4B74-B276-33EDD758D4D6 Q35852574-FBB750DB-0DF5-4326-82C8-7E6742B1CC8C Q35865581-AFD6E3BD-EBA9-42BC-9B24-56583934E1BD Q36060298-43F203B9-F7AB-4917-9F71-8929B74FC17C Q36108614-CA963AA7-B043-441A-A8C8-21F9829FF60A Q36117230-5FA121F4-74F8-4B49-93BF-908C1B8B64A2

P2860

Dendritic cells are functionally defective in multiple myeloma: the role of interleukin-6.

http://www.wikidata.org/entity/Q51045048

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh-hant

name

Dendritic cells are functional ...... ma: the role of interleukin-6.

@en

Dendritic cells are functional ...... ma: the role of interleukin-6.

@nl

type

label

Dendritic cells are functional ...... ma: the role of interleukin-6.

@en

Dendritic cells are functional ...... ma: the role of interleukin-6.

@nl

prefLabel

Dendritic cells are functional ...... ma: the role of interleukin-6.

@en

Dendritic cells are functional ...... ma: the role of interleukin-6.

@nl

P1433

Q51045048-7CBB6A0B-7A49-4227-AC6B-EF38F3CC8F03

P1476

Q51045048-D9F66FF2-76F5-4C7D-8B6C-96E3298977F1

P2093

Q51045048-0023BF89-8D34-482D-AAEF-943C9E8E91C4

Q51045048-015D6A4E-B4EA-4E18-8A00-AA0BB21345C2

Q51045048-3F6FB031-5FAD-44DD-BB2A-CAA4C61F1909

Q51045048-4BC65D4F-C0B1-46FB-8F94-130B831C8959

Q51045048-4DA8FE18-0873-4CC3-8BD1-1AF8ED81C3FE

Q51045048-7131382B-BB13-47CC-B306-6346C7828CC2

Q51045048-98211996-A589-475A-8E97-A83CFB182AB9

Q51045048-CF78F4EA-F69E-42B6-A604-FE7463A00D95

Q51045048-D7B2F033-07A6-49D7-8874-73B3B4CDBB3A

Q51045048-DFEC72A1-1A22-4427-A761-6A680EA28634

P304

Q51045048-E4A1DA69-0EF6-45A9-A46B-5DF6A2135C57

P31

Q51045048-6FE4EE7B-1814-40CE-8EBC-80BFDA652BF2

P356

Q51045048-1BE7940D-5B3B-40DF-8FF5-4688F556041F

P407

Q51045048-09F26D19-704A-456A-8208-B072AD663B34

P433

Q51045048-039E711B-10C2-4A09-AA5B-D6D27E4CC6C8

P478

Q51045048-B1D01453-0E8A-44DF-A30D-57837594964E

P50

Q51045048-90B6D84F-C320-42B8-81AF-85C660A6081C

Q51045048-933E4C95-6184-4055-9557-3E57AD7534F1

P577

Q51045048-A813DD05-58CC-4343-B56C-FDDA46A601D2

P698

Q51045048-925B729E-04A4-4116-ABB5-C1E1B0349FD1

P921

Q51045048-b7eb7141-4e5f-490b-bcc0-9befdcf65995

P356

BLOOD.V100.1.230

P1433

P1476

Dendritic cells are functional ...... ma: the role of interleukin-6.

@en

P2093

Antonio Curti

http://www.w3.org/2001/XMLSchema#string

Elisa Ferri

http://www.w3.org/2001/XMLSchema#string

Francesco Fagnoni

http://www.w3.org/2001/XMLSchema#string

Gioacchino Robustelli Della Cuna

http://www.w3.org/2001/XMLSchema#string

Marina Ratta

http://www.w3.org/2001/XMLSchema#string

Miriam Fogli

http://www.w3.org/2001/XMLSchema#string

Paolo Sansoni

http://www.w3.org/2001/XMLSchema#string

Roberto M Lemoli

http://www.w3.org/2001/XMLSchema#string

Rosanna Vescovini

http://www.w3.org/2001/XMLSchema#string

Sante Tura

http://www.w3.org/2001/XMLSchema#string

P304

230-237

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD.V100.1.230

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

100

http://www.w3.org/2001/XMLSchema#string

P50

Barbara Oliviero

Michele Baccarani

P577

2002-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12070032

http://www.w3.org/2001/XMLSchema#string

P921